Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Retention and dropout from sublingual and extended-release buprenorphine treatment

A comparative analysis of data from a nationally representative sample of commercially-insured people with opioid use disorder in the United States

Bibliographic Data

ID14908285
AuthorsRoman Ivasiy (0000-0002-8405-1360, Yale University, corresponding author), Lynn Madden (0000-0002-9981-3938, APT Foundation), Kimberly Johnson (0000-0002-7835-5288, University of South Florida), KIMBERLY A JOHNSON (0000-0002-2179-5688), Eteri Machavariani (0000-0001-8138-2300, Yale University), Bachar Ahmad (0000-0003-3536-1052, Yale University), David Oliveros (0009-0008-2054-6605, Yale University), Jiale Tan (0000-0002-2694-7310, University of Michigan), Natalie Kil (Yale University), Frederick L Altice (0000-0002-7860-693X, Yale University)
Year2025
Volume138
Pages104748
Publication date2025-04-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueInternational Journal of Drug Policy (JOURNAL)
Journal identifiersISSN: 0955-3959 • E-ISSN: 1873-4758
PublisherElsevier BV (PUBLISHER)
DOI10.1016/j.drugpo.2025.104748
PMID40020306
OpenAlexW4408019156
LanguageEN
Citations received4
References cited48

Buprenorphine · Dropout (neural networks · Opioid · Opioid use disorder · Psychiatry · Sample (material · Clinical Psychology · HIV, Drug Use, Sexual Risk · Medicine · Opioid Use Disorder Treatment · Psychology · Substance Abuse Treatment and Outcomes

  • The matter of mattering in depot buprenorphine treatment

    Open Access•Mia Arp Fallov, Christian Li Kristensen et al.•International Journal of Drug…•2026

  • Initiation, retention, and discontinuation of extended-release buprenorphine (BUP-XR) for opioid dependence

    Open Access•Sofiia Ohorodnik, Kyle Conroy et al.•International Journal of Drug…•2026

  • Re

    Open Access•Angela M DeVeaugh-Geiss, Angela DeVeaugh‐Geiss et al.•International Journal of Drug…•2025

  • Interpreting extended-release buprenorphine data

    Open Access•Michelle R Lofwall, Natalie R Budilovsky-Kelley•International Journal of Drug…•2025

  • Mortality risk during and after opioid substitution treatment

    Open Access•Luis Sordo, Gregorio Barrio et al.•BMJ•2017

  • Medication-Assisted Therapies — Tackling the Opioid-Overdose Epidemic

    Nora D Volkow, Thomas R Frieden et al.•New England Journal of Medicine•2014

  • Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality

    Open Access•Marc R Larochelle, Dana Bernson et al.•Annals of Internal Medicine•2018

  • Global patterns of opioid use and dependence

    Open Access•Louisa Degenhardt, J Grebely et al.•The Lancet•2019

  • Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016

    Open Access•Hawre Jalal, Jeanine M Buchanich et al.•Science•2018

  • Has the treatment gap for opioid use disorder narrowed in the U.S

    Open Access•Noa Krawczyk, Bianca D Rivera et al.•International Journal of Drug…•2022

  • A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System

    Open Access•Christine E Grella, Erika Ostile et al.•International Journal of Drug…•2020

  • Opioid Agonist Treatments and Heroin Overdose Deaths in Baltimore, Maryland, 1995–2009

    Robert P Schwartz, Jan Gryczynski et al.•American Journal of Public Health•2013

  • Understanding Racial Inequities in the Implementation of Harm Reduction Initiatives

    A M Lopez, Matthew Thomann et al.•American Journal of Public Health•2022

Unique citing works4
Citations per year4
Citation span2025 - 2026 (2)
Citation velocitycurrent
Highly citedNo
Citation typesNeutral: 4
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae